Sources: 1BitterDB, 4ClinicalTrials, 7Cochrane Library, 10DGIdb, 14DrugBank, 29HMDB, 33IUPHAR, 46NDF-RT, 50Novoseek, 56PharmGKB, 68UMLSSee all MalaCards sources |
Drugs for Mumps (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 65)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Antibodies | | Phase 4, Phase 2, Phase 1 | 6394 | | | | 2 | | Vaccines | | Phase 4, Phase 2, Phase 3, Phase 1, Early Phase 1 | 6611 | | | | 3 | | Immunoglobulins | | Phase 4, Phase 2, Phase 1 | 6394 | | | | 4 | | Heptavalent Pneumococcal Conjugate Vaccine | | Phase 4, Phase 3, Phase 2 | 465 | | | | 5 | | Pharmaceutical Solutions | | Phase 4, Phase 3, Phase 2 | 8192 | | | | 6 | | Liver Extracts | | Phase 4 | 4067 | | | | 7 | | Aluminum hydroxide | approved | Phase 3, Phase 2 | 210 | 21645-51-2 | | Al(OH)3 Aluminium hydroxide Aluminium hydroxide gel, dried | Aluminium hydroxide, dried Aluminum hydroxide gel, dried Aluminum hydroxide, dried Dried aluminium hydroxide Dried aluminum hydroxide gel |
| | 8 | | Tetracycline | approved, vet_approved | Phase 3, Phase 2 | 105 | 60-54-8 | 5353990 | (-)-Tetracycline (4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide 6-Methyl-1,11-dioxy-2-naphthacenecarboxamide 60-54-8 64-75-5 (mono-hydrochloride) 6591-49-7 87128_FLUKA 87128_SIGMA AC-13151 AC1L1KAT AC1NQXT7 AC1NRDAM AC1NS4RQ AC1NSDX8 AC1NTUT2 AC1NUZHL AC1O52HS Abramycin Abricycline Achromycin Achromycin (naphthacene derivative) Achromycin V Achromycin, naphthacene derivative Agromicina Ambramicina Ambramycin Amycin Anhydrotetracycline BIDD:GT0653 BPBio1_000242 BSPBio_000220 BSPBio_001950 Bio-tetra Biocycline Bristaciclin Bristaciclin .alpha. Bristaciclina Bristacycline C06570 CHEBI:27902 CHEMBL1440 CID12309720 CID5280962 CID5289435 CID5353990 CID5359245 CID5388997 CID5412 CID5497101 CID6426717 Cefracycline Cefracycline suspension Centet (base) Ciclibion Copharlan Criseociclina Cyclomycin Cyclopar Cytome D00201 DB00759 Democracin Deschlorobiomycin DivK1c_000827 Dumocyclin EINECS 200-481-9 Enterocycline HMS2090B04 HSDB 3188 Hostacyclin IDI1_000827 KBio1_000827 KBio2_001514 KBio2_004082 KBio2_006650 KBio3_001450 KBioGR_000783 KBioSS_001514 LS-187078 LS-93869 Lemtrex (base) Lexacycline Limecycline Liquamycin Liquamycin (Veterinary) | Liquamycin, veterinary MLS000069728 Medocycline Mericycline Micycline MolPort-001-794-633 MolPort-003-983-460 MolPort-005-934-198 NCGC00161665-01 NINDS_000827 NSC 108579 NSC108579 Neocycline Omegamycin Orlycycline Panmycin Piracaps (base) Polycycline Polycycline (VAN) Polycycline (antibiotic) Polycycline, antibiotic Polyotic Prestwick0_000140 Prestwick1_000140 Prestwick2_000140 Prestwick3_000140 Purocyclina Resteclin Robitet Roviciclina SK-Tetracycline SMR000058220 SPBio_001457 SPBio_002159 STOCK1N-42738 Sanclomycine Solvocin Spectrum2_001329 Spectrum3_000565 Spectrum4_000352 Spectrum5_001112 Spectrum_001034 Sumycin Sumycin (TN) Sumycin syrup T-125 T3258_SIGMA Tetra-Co Tetrabon Tetrachel Tetraciclina Tetraciclina [INN-Spanish] Tetracycl Tetracyclin Tetracycline & VRC3375 Tetracycline (JAN/USP/INN) Tetracycline (internal use) Tetracycline Free Base Tetracycline HCl Tetracycline I Tetracycline II Tetracycline Monohydrochloride Tetracycline [USAN:INN:BAN:JAN] Tetracyclinum Tetracyclinum [INN-Latin] Tetracyn Tetradecin Tetrafil Tetraverine Tetrazyklin Topicycline Tsiklomistsin Tsiklomitsin Tétracycline UNII-F8VB5M810T UPCMLD-DP127 UPCMLD-DP127:001 UPCMLD-DP127:002 Veracin Vetacyclinum Vetquamycin-324 (free base) WLN: L E6 C666 BV FV CU GUTTT&J DQ EQ GVZ HQ IN1&1 MQ M1 RQ component of Tetrastatin methyl-1,11-dioxo-2-naphthacenecarboxamide nchembio.273-comp1 nchembio.289-comp1 tetracycline |
| | 9 | | Anti-Bacterial Agents | | Phase 3, Phase 2 | 11226 | | | | 10 | | Anti-Infective Agents | | Phase 3, Phase 2 | 22062 | | | | 11 | | PENTA | | Phase 3, Phase 2 | 109 | | | | 12 | | Lactitol | | Phase 3, Phase 2 | 336 | 585-86-4 | 3871 | 4-O-b-D-Galactopyranosyl-D-glucitol, 9CI E966 Emportal | Floralac Importal Oponaf Portolac | |
| | 13 | | Altretamine | approved | Phase 2 | 65 | 645-05-6 | 2123 | 2,4, 6-Tris(dimethylamino)-1,3,5-triazine 2,4,6-Tris(dimethylami 2,4,6-Tris(dimethylamino)-1,3,5-triazine 2,4,6-Tris(dimethylamino)-S-triazine 2,4,6-Tris(dimethylamino)-s-triazine 2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine 549835_ALDRICH 645-05-6 A 8723 A0567/0026158 A8723_SIGMA AB00052308 AC-12006 AC1L1CYX AI3-50852 AKOS001729401 Altretamin Altretamina Altretamina [INN-Spanish] Altretamine (USP/INN) Altretamine Bellon Brand Altretamine Chiesi Brand Altretamine Wassermann Brand Altretamine [USAN:INN:BAN] Altretaminum Altretaminum [INN-Latin] Altrétamine BPBio1_001004 BRD-K67043667-001-04-1 BRN 0195058 BSPBio_000912 Bellon Brand of Altretamine C9H18N6 CAS-654-05-6 CCRIS 5492 CHEBI:24564 CHEMBL1455 CID2123 CPD000058181 ChemDiv2_005185 Chiesi Brand of Altretamine D006585 D02841 DB00488 DivK1c_000772 EINECS 211-428-4 ENT 50852 EU-0100083 FT-0083576 HEXAMETHYLMELAMINE HMM HMS1383L15 HMS1570N14 HMS1922C05 HMS2090G17 HMS2092H16 HMS502G14 HSDB 7559 HTM HXM Hemel Hexalen Hexalen (TN) Hexalen, Altretamine | Hexamethylmelamine Hexastat Hexinawas I06-0604 IDI1_000772 IDI1_003900 InChI=1/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H KB-913 KBio1_000772 KBio2_001788 KBio2_004356 KBio2_006924 KBio3_002042 KBioGR_001388 KBioSS_001788 LS-1549 Lopac-A-8723 Lopac0_000083 MGI Pharma Brand of Altretamine MLS000069621 MLS001076123 MolPort-002-111-210 N,N,N',N',N'',N''-hexamethyl-1,3,5-triazine-2,4,6-triamine NC 195 NCGC00015100-01 NCGC00015100-02 NCGC00015100-03 NCGC00015100-06 NCGC00015100-11 NCGC00021216-03 NCGC00021216-04 NCGC00021216-05 NCGC00021216-06 NCGC00021216-07 NCI-C50259 NCI60_000871 NINDS_000772 NSC 13875 NSC-13875 NSC13875 N~2~,N~2~,N~4~,N~4~,N~6~,N~6~-Hexamethyl-1,3,5-triazine-2,4,6-triamine Prestwick0_000946 Prestwick1_000946 Prestwick2_000946 Prestwick3_000946 Rhone Poulenc Rorer Brand of Altretamine Rhone-Poulenc Rorer Brand of Altretamine S1278_Selleck SAM002564241 SMR000058181 SPBio_000754 SPBio_003071 SPECTRUM1503065 ST086739 STK749184 Spectrum2_000907 Spectrum3_000951 Spectrum4_001064 Spectrum5_001092 Spectrum_001308 UNII-Q8BIH59O7H WLN: T6N CN ENJ BN1&1 DN1&1 FN1&1 Wassermann Brand of Altretamine ZINC00000905 altretamine no)-s-triazine |
| | 14 | | Daclizumab | approved, investigational | Phase 2 | 98 | 152923-56-3 | | Dacliximab Daclizumab beta | |
| | 15 | | Obinutuzumab | approved | Phase 2, Phase 1 | 105 | 949142-50-1 | | | | 16 | | Prednisolone | approved, vet_approved | Phase 2 | 1193 | 50-24-8 | 5755 | (11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione .DELTA.1-Cortisol .DELTA.1-Dehydrocortisol .DELTA.1-Dehydrohydrocortisone .DELTA.1-Hydrocortisone .delta.-Cortef .delta.-Stab 1,2-Dehydrohydrocortisone 1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione 1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol 1-Dehydrocortisol 1-Dehydrohydrocortisone 3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene 46656_FLUKA 46656_RIEDEL 50-24-8 58201-11-9 8056-11-9 AC-1773 AC1L1L2E Ak-Pred Ak-Tate Alphadrol Articulose-50 BPBio1_000164 BRD-K98039984-001-03-0 BRN 1354103 BSPBio_000148 Bio-0666 Bubbli-Pred C07369 CCRIS 980 CHEBI:8378 CHEMBL131 CID5755 CO-Hydeltra CPD000718761 Co-Hydeltra Codelcortone Cordrol Cortalone Cotogesic Cotolone D00472 D011239 DB00860 Decaprednil Decortin H Delcortol Delta F Delta(1)-dehydrohydrocortisone Delta-Cortef Delta-Cortef (TN) Delta-Ef-Cortelan Delta-Stab Delta-stab Deltacortenol Deltacortril Deltacortril Enteric Deltahydrocortisone Deltasolone Deltisilone Depo-Medrol Derpo PD Derpo Pd Dexa-Cortidelt Hostacortin H Dexa-Cortidelt hostacortin H Di Adreson F Di-Adreson F Di-Adreson-F Di-adreson F DiAdresonF Dicortol Donisolone Dydeltrone EINECS 200-021-7 Eazolin D Econopred Econopred Plus Erbacort Erbasona Estilsona Fernisolone Fernisolone P Fernisolone-P Flamasone HMS1568H10 HMS2090J05 HSDB 3385 Hostacortin H Hydeltra Hydeltra-Tba Hydeltrasol Hydeltrone Hydrodeltalone Hydrodeltisone Hydroretrocortin Hydroretrocortine I-Pred Inflamase Forte Inflamase Mild K 1557 Key-Pred Klismacort LMST02030179 LS-7669 Lentosone Lite Pred M-Predrol | MLS001304083 MLS002154250 MLS002207037 Medrol Medrol Acetate Metacortandralone Methylprednisolone Acetate Meti-Derm Meticortelone Metreton MolPort-002-507-147 NCGC00179649-01 NSC 9120 NSC9120 NSC9900 Neo-Delta-Cortef Nisolone Nor-Pred T.B.A. Ocu-Pred Ocu-Pred Forte Ophtho-Tate Orapred P0152_SIGMA P0637 P6004_SIGMA PRDL PRED-G Panafcortelone Paracortol Paracotol Pediapred Poly-Pred Precortalon Precortancyl Precortilon Precortisyl Pred Forte Pred Mild Predair Predair A Predair Forte Predalone 50 Predalone T.B.A. Predate Predate Tba Predate-50 Predcor-25 Predcor-50 Predcor-Tba Predisolone Sodium Phosphate Predne-Dome Prednelan Predni-Dome Prednicen Predniliderm Predniretard Prednis Prednisolona Prednisolona [INN-Spanish] Prednisolone (JP15/USP/INN) Prednisolone (anhydrous) Prednisolone Acetate Prednisolone Sodium Phosphate Prednisolone Tebutate Prednisolone [INN:BAN:JAN] Prednisolonum Prednisolonum [INN-Latin] Predonin Predonine Prelone Prenolone Prestwick0_000274 Prestwick1_000274 Prestwick2_000274 Prestwick3_000274 Prestwick_404 Rolisone S1737_Selleck SAM002264639 SMR000718761 SPBio_002367 Scherisolon Solone Steran Sterane Sterolone Supercortisol UNII-9PHQ9Y1OLM Ulacort Ultra Pred Ultracorten H Ultracortene H Ultracortene-H Ultracortene-Hydrogen Ultracortene-hydrogen ZINC03833821 component of Ataraxoid component of K-Predne-Dome delta(1)-Cortisol delta(1)-Dehydrocortisol delta(1)-Dehydrohydrocortisone delta(1)-Hydrocortisone delta(sup 1)-Cortisol delta(sup 1)-Dehydrocortisol delta(sup 1)-Dehydrohydrocortisone delta(sup 1)-Hydrocortisone delta-dehydrocortisol delta-dehydrohydrocortisone delta-hydrocortisone prednisolone | |
| | 17 | | Methylprednisolone | approved, vet_approved | Phase 2 | 1193 | 83-43-2 | 6741 | (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one (6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione .DELTA.1-6.alpha.-Methylhydrocortisone 1-Dehydro-6alpha-methylhydrocortisone 1-dehydro-6alpha-Methylhydrocortisone 1-dehydro-6α-methylhydrocortisone 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 121673-01-6 4-08-00-03498 (Beilstein Handbook Reference) 46436_FLUKA 46436_RIEDEL 570-35-4 6 Methylprednisolone 6-Methylprednisolone 6-alpha-Methylprednisolone 6.alpha.-Methylprednisolone 6923-42-8 6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 6alpha-Methylprednisolone 6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 83-43-2 AC1L1N7A Artisone-Wyeth Artisone-wyeth BPBio1_000174 BRD-K35240538-001-03-1 BRN 2340300 BSPBio_000158 Besonia Bio-0658 CHEBI:6888 CHEMBL650 CID6741 CPD000058330 D00407 D008775 DB00959 Depo-Medrol (acetate) Dopomedrol EINECS 201-476-4 Esametone Firmacort HMS1568H20 HMS2090B13 HSDB 3127 LMST02030178 LS-118498 Lemod M0639_SIGMA M1665 MEPRDL MLS000028541 MLS001148159 MLS002207191 Medesone Medixon Medlone 21 | Medrate Medrol Medrol (TN) Medrol Adt Pak Medrol Dosepak Medrol adt pak Medrol dosepak Medrol, Solu-Medrol, Medrone, Methylprednisolone Medrone Mesopren Metastab Methyleneprednisolone Methylprednisolon Methylprednisolone Methylprednisolone (JP15/USP/INN) Methylprednisolone [USAN:INN:BAN:JAN] Methylprednisolone, 6-alpha Methylprednisolonum Methylprednisolonum [INN-Latin] Metilbetasone Metilprednisolona Metilprednisolona [INN-Spanish] Metilprednisolone Metilprednisolone [DCIT] Metilprednisolone [Dcit] Metipred Metrisone Metrocort Metysolon Moderin MolPort-002-528-554 NCGC00022735-03 NCI60_001657 NSC-19987 NSC19987 Nirypan Noretona Predni N Tablinen Prednol- L Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI) Prestwick0_000279 Prestwick1_000279 Prestwick2_000279 Prestwick3_000279 Prestwick_622 Promacortine Reactenol S1733_Selleck SAM002589984 SMR000058330 SPBio_002377 Sieropresol Solomet Summicort Suprametil U 7532 UNII-X4W7ZR7023 Urbason Urbasone Wyacort ZINC03875560 delta(1)-6alpha-Methylhydrocortisone delta(sup 1)-6-alpha-Methylhydrocortisone methylprednisolone methylprenisolone |
| | 18 | | Mycophenolic acid | approved | Phase 2 | 952 | 24280-93-1 | 446541 | (e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid Acide mycophenolique Acido micofenolico Acidum mycophenolicum | Melbex Micofenolico acido Mycophenoic acid Mycophenolate Mycophenolsäure Myfortic |
| | 19 | | Mycophenolate mofetil | approved, investigational | Phase 2 | 952 | 128794-94-5 | 5281078 | 115007-34-6 128794-94-5 140401-05-4 2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate 2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E) AC-1562 AC1NQXZW AC1Q6O6X AR-1J6939 BB_NC-2566 C07908 C23H31NO7 CHEMBL1456 CID5281078 CellCept CellCept, RS 61443, TM-MMF, Mycophenolate mofetil Cellcept Cellcept (TN) D00752 DB00688 HMS2090A03 | HSDB 7436 I01-0898 I06-1947 LS-172272 LS-75572 ME-MPA MMF MMF CellCept(TM) MolPort-000-883-800 Munoloc Mycophenolate mofetil (JAN/USAN) Mycophenolic acid morpholinoethyl ester Mycophenylate mofetil NCGC00159459-02 NCGC00159459-03 NSC724229 R-99 RS 61443 RS-61443 RS-61443-190 S1501_Selleck TL8000648 TM-MMF UNII-9242ECW6R0 ZINC21297660 mycophenolate mofetil | |
| | 20 | | Prednisone | approved, vet_approved | Phase 2 | 1398 | 53-03-2 | 5865 | (1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione (8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione (8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione .delta. E .delta.(sup1)-Cortisone .delta.-Cortelan .delta.-Cortisone .delta.-Cortone .delta.-E .delta.1-Cortisone .delta.1-Dehydrocortisone .delta.sone 1,2-Dehydrocortisone 1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione 1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione 1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione 1-Cortisone 1-Dehydrocortisone 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione 17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione 53-03-2 68-59-7 81552_FLUKA AC-11112 AC1L1LB2 AC1Q29EZ ACon0_000082 ACon1_000297 AI3-52939 Adasone Ancortone Apo-Prednisone Apo-prednisone BPBio1_000323 BRD-K85883481-001-04-2 BSPBio_000293 Betapar Bicortone Bio-0649 C07370 C21H26O5 CCRIS 2646 CHEBI:8382 CHEMBL635 CID5865 CPD001227202 Cartancyl Colisone Cortan Cortancyl Cortidelt Cotone DB00635 Dacorten Dacortin Decortancyl Decortin Decortisyl Dehydrocortisone Dekortin Delcortin Dellacort Dellacort A Delta Cortelan Delta E Delta E. Delta-Cortelan Delta-Dome Delta-cortelan Delta-cortisone Delta-cortone Delta-dome Deltacortene Deltacortisone Deltacortone Deltasone Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone Deltison Deltisona Deltisone Deltra Di-Adreson Diadreson EINECS 200-160-3 Econosone Encorton Encortone Enkortolon Enkorton Fernisone Fiasone HMS1568O15 HMS2090J13 HSDB 3168 Hostacortin In-Sone Incocortyl | Juvason Kortancyl LMST02030180 LS-1325 Liquid Pred Lisacort Lodotra MEGxm0_000443 MLS001061265 MLS001304073 MLS001335907 MLS001335908 MLS002154191 MLS002207083 Me-Korti Metacortandracin Meticorten Meticorten (Veterinary) Metrevet (Veterinary) MolPort-001-740-041 NCGC00090766-01 NCGC00090766-02 NCGC00090766-03 NCI-C04897 NCI60_000008 NSC 10023 NSC10023 Nisona Nizon Novoprednisone Nurison Orasone Origen Prednisone P1276 P6254_SIGMA PRD Panafcort Panasol Paracort Parmenison Pehacort Precort Predeltin Prednicen-M Prednicorm Prednicort Prednicot Prednidib Prednilonga Prednison Prednisona Prednisona [INN-Spanish] Prednisone Prednisone Intensol Prednisone [INN:BAN] Prednisonum Prednisonum [INN-Latin] Prednitone Prednizon Prednovister Presone Prestwick0_000077 Prestwick1_000077 Prestwick2_000077 Prestwick3_000077 Prestwick_405 Pronison Pronisone Rectodelt Retrocortine S1622_Selleck SAM002264641 SK-Prednisone SMR000718760 SMR001227202 SPBio_002214 Servisone Sone Sterapred Supercortil U 6020 UNII-VB0R961HZT Ultracorten Ultracortene WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ Winpred Wojtab ZINC03875357 Zenadrid Zenadrid (veterinary) Zenadrid [veterinary] delta cortelan delta(sup 1)-Cortisone delta(sup 1)-Dehydrocortisone delta-1-Cortisone delta-1-Dehydrocortisone delta-Cortisone delta-Cortone | |
| | 21 | | Peripheral Nervous System Agents | | Phase 2 | 23689 | | | | 22 | | Antibodies, Monoclonal | | Phase 2 | 4039 | | | | 23 | | Immunoglobulin G | | Phase 2 | 275 | | | | 24 | | Fibrinolytic Agents | | Phase 2 | 2388 | | | | 25 | | Anticoagulants | | Phase 2 | 2623 | | | | 26 | | Immunosuppressive Agents | | Phase 2 | 13086 | | | | 27 | | Interleukin-2 | | Phase 2 | 571 | | | | 28 | | Prednisolone hemisuccinate | | Phase 2 | 1193 | | | | 29 | | Prednisolone acetate | | Phase 2 | 1193 | | | | 30 | | Protective Agents | | Phase 2 | 7443 | | | | 31 | | Neuroprotective Agents | | Phase 2 | 1716 | | | | 32 | | Prednisolone phosphate | | Phase 2 | 1193 | | | | 33 | | Methylprednisolone Hemisuccinate | | Phase 2 | 1193 | | | | 34 | | Antineoplastic Agents, Hormonal | | Phase 2 | 5592 | | | | 35 | | Anti-Inflammatory Agents | | Phase 2 | 10729 | | | | 36 | | Antiemetics | | Phase 2 | 4022 | | | | 37 | | Methylprednisolone acetate | | Phase 2 | 1193 | | | | 38 | | Autonomic Agents | | Phase 2 | 10150 | | | | 39 | | Antibiotics, Antitubercular | | Phase 2 | 7180 | | | | 40 | | Hormones, Hormone Substitutes, and Hormone Antagonists | | Phase 2 | 13168 | | | | 41 | | Gastrointestinal Agents | | Phase 2 | 8402 | | | | 42 | | Hormones | | Phase 2 | 14415 | | | | 43 | | Hormone Antagonists | | Phase 2 | 13180 | | | | 44 | | glucocorticoids | | Phase 2 | 5103 | | | | 45 | | Immunoglobulins, Intravenous | | Phase 1 | 333 | | | | 46 | | Rho(D) Immune Globulin | | Phase 1 | 326 | | | | 47 | | gamma-Globulins | | Phase 1 | 326 | | | | 48 | | Acetylcholine | approved | | 805 | 51-84-3 | 187 | ACh Acetyl choline ion Acetylcholine Chloride Acetylcholine cation | Acetylcholinium: acetyl-Choline Choline acetate Choline acetate (ester) O-Acetylcholine acetylcholine chloride | |
| | 49 | | Azathioprine | approved | | 177 | 446-86-6 | 2265 | 446-86-6 55774-33-9 (hydrochloride salt) 6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine 6-((1-Methyl-4-nitroimidazol-5-yl)thio)purine 6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine 6-(1'-Methyl-4'-nitro-5'-imidazolyl)mercaptopurine 6-(1-Methyl-4-nitroimidazol-5-yl)thiopurine 6-(1-Methyl-4-nitroimidazol-5-ylthio)purin 6-(1-Methyl-4-nitroimidazol-5-ylthio)purin [Czech] 6-(1-Methyl-p-nitro-5-imidazolyl)-thiopurine 6-(1-Methyl-p-nitro-5-imidazolyl)thiopurine 6-(3-Methyl-5-nitro-3H-imidazol-4-ylsulfanyl)-7H-purine 6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine 6-(Methyl-p-nitro-5-imidazolyl)-thiopurine 6-(Methyl-p-nitro-5-imidazolyl)thiopurine 6-({4-nitro-1-methyl-1H-imidazol-5-yl}sulfanyl)-7H-purine 6-1'-Methyl,4'-nitro,5'-imidazolyl mercaptopurine 6-[(1-Methyl-4-nitroimidazol-5-yl)- thio] purine 6-[(1-Methyl-4-nitroimidazol-5-yl)thio]purine 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-Purine 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-7H-purine 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purine A 4638 A2593_SIAL A4638_SIAL A4638_SIGMA AB00443544 AB00443544-03 AC-4230 AC1L1DAL AC1Q3Z1F AI-981/34845012 AI3-50290 Azamun Azamun [Czech] Azanin Azasan Azasan (TN) Azasan, Imuran, Azamun, BW-57-322, NSC-39084, Azathioprine Azathioprin Azathioprine (JP15/USP/INN) Azathioprine Sodium Azathioprine [USAN:INN:BAN:JAN] Azathioprine sodium Azathioprinum Azathioprinum [INN-Latin] Azathiopurine Azatioprin Azatioprina Azatioprina [INN-Spanish] Azothioprine B. W. 57-322 BPBio1_000054 BRD-K32821942-001-05-6 BRD-K60324116-001-01-5 BSPBio_000048 BSPBio_001876 BW 57-322 BW 57322 BW-57-322 C06837 C9H7N7O2S CAS-446-86-6 CBDivE_013132 CCRIS 62 CHEBI:2948 CHEMBL1542 CID2265 CPD000427366 Ccucol ChemDiv1_002659 Cytostatics D00238 DB00993 DivK1c_000586 EINECS 207-175-4 EU-0100027 FT-0083532 HMS1568C10 HMS1920E17 | HMS2091K19 HMS501N08 HMS594I19 HSDB 7084 IDI1_000586 Immuran Imuran Imuran (TN) Imuran (tn) Imurek Imurel KBio1_000586 KBio2_000464 KBio2_002427 KBio2_003032 KBio2_004995 KBio2_005600 KBio2_007563 KBio3_001376 KBio3_002906 KBioGR_000646 KBioGR_002427 KBioSS_000464 KBioSS_002433 LS-123 Lopac-A-4638 Lopac0_000027 MLS001049307 Methylnitroimidazolylmercaptopurine MolPort-000-745-914 MolPort-000-764-262 MolPort-003-665-485 Muran NCGC00015060-01 NCGC00015060-02 NCGC00015060-04 NCGC00015060-12 NCGC00090836-01 NCGC00090836-02 NCGC00090836-03 NCGC00090836-04 NCGC00090836-05 NCGC00090836-06 NCGC00094593-01 NCGC00094593-02 NCGC00094593-03 NCI-C03474 NINDS_000586 NSC 39084 NSC-39084 NSC39084 Oprea1_375441 Oprea1_533384 Oprea1_633462 Prestwick0_000094 Prestwick1_000094 Prestwick2_000094 Prestwick3_000094 Prestwick_41 S1721_Selleck SAM002589938 SDCCGMLS-0065415.P001 SMR000427366 SPBio_000255 SPBio_001987 SPECTRUM1500133 STK831906 STOCK1S-20293 STOCK1S-27186 Spectrum2_000068 Spectrum3_000308 Spectrum4_000243 Spectrum5_000848 Spectrum_000064 Thiopurine 6-(1-methyl-4-nitroimidazol-5-yl) UNII-MRK240IY2L WLN: T56 BM DN FN HNJ IS- ET5N CNJ A1 DNW ZINC04258316 [Methyl(nitroimidazolyl)mercaptopurine] azathioprine azatiopr in cMAP_000046 | |
| | 50 | | Adalimumab | approved | | 494 | 331731-18-1 | 16219006 | 331731-18-1 Adalimumab Adalimumab (USAN/INN) Adalimumab (genetical recombination) | Adalimumab (genetical recombination) (JAN) D02597 Humira Humira (TN) Humira Pen Ig gamma-1 chain C region |
|
Interventional clinical trials: (show top 50)
(show all 131)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine | Unknown status | NCT02153866 | Phase 4 | | 2 | Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases | Completed | NCT00126997 | Phase 4 | | 3 | Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis | Completed | NCT00731965 | Phase 4 | | 4 | Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations | Completed | NCT01777529 | Phase 4 | | 5 | Measles, Mumps, and Rubella (MMR) Immunity in College Students | Completed | NCT00962819 | Phase 4 | | 6 | Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine | Completed | NCT00313950 | Phase 4 | | 7 | Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine | Completed | NCT03160820 | Phase 4 | | 8 | MMR Vaccination Among HIV-infected Adults | Completed | NCT02724852 | Phase 4 | | 9 | Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED) | Completed | NCT00326183 | Phase 4 | | 10 | Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067) | Completed | NCT00312858 | Phase 4 | | 11 | Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore. | Completed | NCT00388440 | Phase 4 | | 12 | MMR and Varicella Vaccine in Premature Infants | Completed | NCT00156559 | Phase 4 | | 13 | Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old Children | Completed | NCT02253407 | Phase 4 | | 14 | Safety Study of a Refrigerator-stable Formulation of VARIVAX® | Completed | NCT00432731 | Phase 4 | | 15 | Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV | Completed | NCT00329251 | Phase 4 | | 16 | Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella Vaccine | Recruiting | NCT02880865 | Phase 4 | | 17 | Homeopathic Vaccine Trial | Recruiting | NCT02825368 | Phase 4 | | 18 | Induction of Immunity Against Measles in Pediatric Liver Transplant Recipients | Recruiting | NCT01770119 | Phase 4 | | 19 | Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR | Active, not recruiting | NCT02325310 | Phase 4 | | 20 | Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines | Terminated | NCT00138255 | Phase 4 | | 21 | Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants | Unknown status | NCT01763268 | Phase 2, Phase 3 | | 22 | A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED) | Completed | NCT00092391 | Phase 3 | | 23 | Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases | Completed | NCT00127023 | Phase 3 | | 24 | Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases | Completed | NCT00127010 | Phase 3 | | 25 | Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older | Completed | NCT02058563 | Phase 3 | | 26 | Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers | Completed | NCT01188343 | Phase 3 | | 27 | Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027) | Completed | NCT01536405 | Phase 3 | | 28 | Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016) | Completed | NCT00092430 | Phase 3 | | 29 | Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months. | Completed | NCT01991899 | Phase 3 | | 30 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life | Completed | NCT01681992 | Phase 3 | | 31 | Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age | Completed | NCT02184572 | Phase 3 | | 32 | Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136 | Completed | NCT00751348 | Phase 3 | | 33 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age | Completed | NCT01621802 | Phase 3 | | 34 | Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children | Completed | NCT00192491 | Phase 3 | | 35 | Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children | Completed | NCT00197015 | Phase 3 | | 36 | Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox | Completed | NCT00226499 | Phase 3 | | 37 | ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED) | Completed | NCT00975507 | Phase 3 | | 38 | Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM | Completed | NCT00969436 | Phase 3 | | 39 | Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children | Completed | NCT01506193 | Phase 3 | | 40 | ProQuad® rHA Safety | Completed | NCT00560755 | Phase 3 | | 41 | Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly | Completed | NCT00432042 | Phase 3 | | 42 | Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine | Completed | NCT00406211 | Phase 3 | | 43 | Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix®) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M M R®II), in Children 12 to 15 Months of Age | Completed | NCT01702428 | Phase 3 | | 44 | Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED) | Completed | NCT00985153 | Phase 3 | | 45 | A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014) | Completed | NCT00985166 | Phase 3 | | 46 | Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers | Completed | NCT00422292 | Phase 3 | | 47 | ProQuad® Intramuscular vs Subcutaneous | Completed | NCT00402831 | Phase 3 | | 48 | Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route | Completed | NCT00432523 | Phase 3 | | 49 | Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA | Completed | NCT00566527 | Phase 3 | | 50 | Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years | Completed | NCT00871117 | Phase 3 |
Cochrane evidence based reviews: mumps
|
